Clinical Endocrinology · 1999 · 34 citations · 7 references
MedicinePathologyPharmacotherapyAutoimmunityImmunopathologyInflammationAutoimmune DiseasesPancreatic DiseasesPancreatic DisordersAcute ParotitisEnzymesGraves Disease PathologyGraves' Disease TreatmentPancreatic Digestive Enzymes
A wide variety of adverse effects of methimazole (MMI) have been reported. Here we report a new MMI-induced disorder, acute pancreatitis and parotitis. Three weeks after a woman started MMI treatment for Graves' disease, she developed a high fever, painful parotid swelling and dull pain in the upper abdomen with elevation of the serum levels of salivary and pancreatic enzymes. These abnormalities disappeared soon after the withdrawal of MMI. However, the same abnormalities were rapidly provoked when MMI was reintroduced. Marked increases in the leucocyte count and CRP were also observed during these episodes. The possible mechanisms of MMI-induced pancreatitis/parotitis are discussed.
7
Sho Matsushita, K Takahashi, Masao Motoki et al. · The Journal of Experimental Medicine · 1994 · 122 citations · Full text
Yasuko Uchigata, Shoji Kuwata, Takahiro Tsushima et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 68 citations · Full text
John B. Marshall · Archives of Internal Medicine · 1993 · 57 citations
Acute Drug and Toxin Induced Pancreatitis
William M. Steinberg · Hospital Practice · 1985 · 35 citations
Medicine, Pharmacology, Toxicology +13